C5b9 Deposition in Glomerular Capillaries Is Associated With Poor Kidney Allograft Survival in Antibody-Mediated Rejection.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 16 11 2018
accepted: 28 01 2019
entrez: 26 3 2019
pubmed: 25 3 2019
medline: 27 5 2020
Statut: epublish

Résumé

C4d deposition in peritubular capillaries (PTC) reflects complement activation in antibody-mediated rejection (ABMR) of kidney allograft. However, its association with allograft survival is controversial. We hypothesized that capillary deposition of C5b9-indicative of complement-mediated injury-is a severity marker of ABMR. This pilot study aimed to determine the frequency, location and prognostic impact of these deposits in ABMR. We retrospectively selected patients diagnosed with ABMR in two French transplantation centers from January 2005 to December 2014 and performed C4d and C5b9 staining by immunohistochemistry. Fifty-four patients were included. Median follow-up was 52.5 (34.25-73.5) months. Thirteen patients (24%) had C5b9 deposits along glomerular capillaries (GC). Among these, seven (54%) had a global and diffuse staining pattern. Twelve of the C5b9+ patients also had deposition of C4d in GC and PTC. C4d deposits along GC and PTC were not associated with death-censored allograft survival (

Identifiants

pubmed: 30906289
doi: 10.3389/fimmu.2019.00235
pmc: PMC6418012
doi:

Substances chimiques

Antibodies 0
Complement Membrane Attack Complex 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

235

Références

Am J Transplant. 2007 Apr;7(4):832-41
pubmed: 17391126
Clin Exp Immunol. 1991 Dec;86(3):464-70
pubmed: 1747954
Am J Transplant. 2008 Mar;8(3):492-6
pubmed: 18294145
Nat Rev Immunol. 2009 Oct;9(10):729-40
pubmed: 19730437
Am J Transplant. 2011 Nov;11(11):2405-13
pubmed: 21942930
Nat Rev Nephrol. 2012 Apr 17;8(6):348-57
pubmed: 22508180
Transplant Proc. 2012 Sep;44(7):1897-900
pubmed: 22974865
Nat Rev Nephrol. 2012 Nov;8(11):670-8
pubmed: 23026942
Circulation. 2013 Dec 3;128(23):2504-16
pubmed: 24045046
N Engl J Med. 2013 Sep 26;369(13):1215-26
pubmed: 24066742
Am J Transplant. 2014 Feb;14(2):255-71
pubmed: 24401076
Am J Transplant. 2014 Feb;14(2):272-83
pubmed: 24472190
Kidney Int. 2015 Jan;87(1):182-94
pubmed: 24827778
J Am Soc Nephrol. 2015 Feb;26(2):457-67
pubmed: 25125383
Nephrol Dial Transplant. 2015 Nov;30(11):1825-33
pubmed: 25473123
J Am Soc Nephrol. 2015 Jul;26(7):1721-31
pubmed: 25556173
J Am Soc Nephrol. 2015 Sep;26(9):2239-47
pubmed: 25573909
Am J Transplant. 2015 May;15(5):1293-302
pubmed: 25731800
J Am Soc Nephrol. 2015 Nov;26(11):2852-9
pubmed: 25991041
Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):9686-91
pubmed: 26195760
J Am Soc Nephrol. 2016 Jan;27(1):293-304
pubmed: 26293822
Am J Transplant. 2016 Jan;16(1):213-20
pubmed: 26317487
Kidney Int. 2015 Nov;88(5):967-73
pubmed: 26376132
J Immunol. 2015 Dec 15;195(12):5525-31
pubmed: 26637661
Ther Apher Dial. 2016 Jun;20(3):240-5
pubmed: 27312908
Am J Transplant. 2017 Mar;17(3):703-711
pubmed: 27539748
Am J Transplant. 2017 Jan;17(1):28-41
pubmed: 27862883
Transpl Int. 2017 May;30(5):519-532
pubmed: 28207978

Auteurs

Valentin Goutaudier (V)

University of Montpellier, Department of Nephrology, Dialysis and Transplantation, Lapeyronie Hospital, Montpellier University Hospital, Montpellier, France.

Hélène Perrochia (H)

Department of Pathology, Gui de Chauliac Hospital, Montpellier University Hospital, Montpellier, France.

Simon Mucha (S)

Department of Nephrology, Transplantation, Dialysis and Apheresis, Pellegrin Hospital, Bordeaux University Hospital, Bordeaux, France.

Marie Bonnet (M)

University of Montpellier, Department of Nephrology, Dialysis and Transplantation, Lapeyronie Hospital, Montpellier University Hospital, Montpellier, France.

Sylvie Delmas (S)

University of Montpellier, Department of Nephrology, Dialysis and Transplantation, Lapeyronie Hospital, Montpellier University Hospital, Montpellier, France.

Florian Garo (F)

University of Montpellier, Department of Nephrology, Dialysis and Transplantation, Lapeyronie Hospital, Montpellier University Hospital, Montpellier, France.

Valérie Garrigue (V)

University of Montpellier, Department of Nephrology, Dialysis and Transplantation, Lapeyronie Hospital, Montpellier University Hospital, Montpellier, France.

Sébastien Lepreux (S)

Department of Pathology, Pellegrin Hospital, Bordeaux University Hospital, Bordeaux, France.

Vincent Pernin (V)

University of Montpellier, Department of Nephrology, Dialysis and Transplantation, Lapeyronie Hospital, Montpellier University Hospital, Montpellier, France.
INSERM U1183, Institute for Regenerative Medicine and Biotherapy, Saint-Eloi Hospital, Montpellier University Hospital, Montpellier, France.

Jean-Emmanuel Serre (JE)

University of Montpellier, Department of Nephrology, Dialysis and Transplantation, Lapeyronie Hospital, Montpellier University Hospital, Montpellier, France.

Ilan Szwarc (I)

University of Montpellier, Department of Nephrology, Dialysis and Transplantation, Lapeyronie Hospital, Montpellier University Hospital, Montpellier, France.

Pierre Merville (P)

Department of Nephrology, Transplantation, Dialysis and Apheresis, Pellegrin Hospital, Bordeaux University Hospital, Bordeaux, France.
UMR CNRS 5164, ImmunoConcEpT, Bordeaux University, Bordeaux, France.

Annie Ramounau-Pigot (A)

Department of Immunology, Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France.

Céline René (C)

Department of Immunology, Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France.

Jonathan Visentin (J)

UMR CNRS 5164, ImmunoConcEpT, Bordeaux University, Bordeaux, France.
Department of Immunology and Immunogenetics, Pellegrin Hospital, Bordeaux University Hospital, Bordeaux, France.

Bryan Paul Morgan (BP)

School of Medicine, Systems Immunity Research Institute, Cardiff University, Cardiff, United Kingdom.

Véronique Frémeaux-Bacchi (V)

Department of Immunology, Hospital European Georges Pompidou, Paris, France.

Georges Mourad (G)

University of Montpellier, Department of Nephrology, Dialysis and Transplantation, Lapeyronie Hospital, Montpellier University Hospital, Montpellier, France.

Lionel Couzi (L)

Department of Nephrology, Transplantation, Dialysis and Apheresis, Pellegrin Hospital, Bordeaux University Hospital, Bordeaux, France.
UMR CNRS 5164, ImmunoConcEpT, Bordeaux University, Bordeaux, France.

Moglie Le Quintrec (M)

University of Montpellier, Department of Nephrology, Dialysis and Transplantation, Lapeyronie Hospital, Montpellier University Hospital, Montpellier, France.
INSERM U1183, Institute for Regenerative Medicine and Biotherapy, Saint-Eloi Hospital, Montpellier University Hospital, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH